Abbott India informs about analyst meet

26 Sep 2022 Evaluate

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Abbott India has informed that it attached schedule of Investors/Analysts meeting with the Company. There will not be any presentation at the Meeting. Also, no Unpublished Price Sensitive Information pertaining to the Company will be shared during this Meeting. The said intimation is also available on the website of the Company at www.abbott.co.in.

The above information is a part of company’s filings submitted to BSE.

Abbott India Share Price

29946.35 6.75 (0.02%)
07-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1854.15
Dr. Reddys Lab 1350.75
Cipla 1497.80
Lupin 2357.65
Zydus Lifesciences 1001.20
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.